Big endothelin-3-induced hypertension and its inhibition by phosphoramidon in anaesthetized rats

Eur J Pharmacol. 1993 Jan 5;230(1):89-93. doi: 10.1016/0014-2999(93)90414-d.

Abstract

Intravenous injection of big endothelin-3 (big ET-3, 1-41 amide) at 3 nmol/kg to ganglion-blocked anaesthetized rats produced a long-lasting hypertensive action, but the action was less potent than that seen with the same dose of ET-3-(1-21). The pressor effect induced by big ET-3 was markedly attenuated by pretreatment with phosphoramidon, 5 mg/kg i.v., a dose which had no effect on the hypertensive action induced by ET-3. These results strongly suggest that big ET-3 is converted to mature ET-3 by a phosphoramidon-sensitive metalloproteinase in vivo, in a manner similar to the conversion of big ET-1 to ET-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthesia
  • Animals
  • Blood Pressure / drug effects*
  • Endothelin-1
  • Endothelins / antagonists & inhibitors
  • Endothelins / pharmacology*
  • Ganglionic Blockers
  • Glycopeptides / pharmacology*
  • Male
  • Protein Precursors / antagonists & inhibitors
  • Protein Precursors / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Thermolysin / antagonists & inhibitors*

Substances

  • Endothelin-1
  • Endothelins
  • Ganglionic Blockers
  • Glycopeptides
  • Protein Precursors
  • Thermolysin
  • phosphoramidon